---

COVID-19 Update

We have been closely monitoring the global pandemic of COVID-19 (also known as Coronavirus and SARS-CoV2) and what it could potentially mean for our conference. We also recognize that this may be international travel for many of you, which can take several months to plan. Based on current travel restrictions and the uncertainty of where the pandemic will be within the next few months, the CMV Public Health and Policy Conference (CMV-PHP) planning committee has made the difficult decision to postpone the 2020 CMV-PHP. Our conference was scheduled for August 30-September 1, 2020 in Ottawa, Ontario. Our hope is to have the conference in late August 2021 in Ottawa, and we will alert you with our finalized conference dates as soon as possible.

The landscape of CMV prevention, screening, and treatment is always changing and one of the goals of the CMV-PHP is to provide the most current research and practice. In an effort to stay true to our goals, we will host some virtual learning opportunities in lieu of the conference on August 31 and September 1, 2020. In addition, we are partnering with CMV Canada and the National CMV Foundation to host CMV livecasts between August 2020-August 2021. Stay tuned for more information.

For those of you who submitted abstracts, thank you—we had more abstracts submitted than we anticipated provided current restrictions on presentations for some organizations. Prior to the 2021 conference, we will reach out to see if you would like your 2020 abstract submission to be considered and give you the option to edit it. We will also be opening the abstract submission for new submissions for those of you who were unable to submit or have new research you would like to present. We will also reach out to a few of you to present your research and practice during our virtual learning opportunities and livecasts.

Please reach out to us with any questions at info@cmvconference.org.

---

The goal of the Congenital CMV conference is to present the latest research on diagnosis and treatment, raise awareness, delineate prevention efforts, provide information about early intervention options, and disseminate family support resources in an effort to reduce the number of babies born with CMV and connect families affected by CMV with the resources they need to improve their quality of life.

With your help, we can reduce the number of babies born with CMV!

Executive Planning Committee:

Eliana Castillo (CA), Jessica Dunn (CA), Karen Fowler (US), Soren Gantt (CA), Mandy Jay (Co-Director, US), Casey Judd (US), Kristen Spytek (US), Rob Tetrault (CA), Alyson Ward (Co-Director, US)

Parent Planning Committee:

Rob & Michelle Tetrault, Lyndsay & Oliver Craig, Lisa & Tyrel Robinson, Mike George, Andrea Stambaugh

Scientific Advisory Committee:

Soren Gantt (co-chair), Jessica Dunn (co-chair), Ari Bitnun, Isabelle Boucoiran, Jason Brophy, Eliana Castillo, Sharon Cushing, Gail Demmler-Harrison, Sheila Dollard, David Goldfarb, Brenna Hughes, Karen Fowler, Fatima Kakkar, Albert Park, Bill Rawlinson, Pablo Sanchez, Mark Schleiss

2020 CMV Conference Partners

This conference was funded in part by a cooperative agreement (U52MC04391) from the Maternal and Child Health Bureau (MCHB) of the Health Resources and Services Administration (HRSA) at the United States Department of Health and Human Services. Opinions expressed by speakers at the conference are their own and no endorsement by MCHB/HRSA is implied or expressed.

CONTACT
EMAIL: info@cmvconference.org
PHONE: 435-797-9493